Synthesis process of doxofylline

A technology of doxofylline and synthesis technology, applied in the field of synthesis technology of doxofylline, can solve the problems of difficulty in purification, many solvents, and high impurity content, and achieves improved reaction yield, fewer side reactions, and reduced impurity content. Effect

Pending Publication Date: 2022-04-22
赤峰万泽药业股份有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this synthesis method introduces more solvents, resulting in high impurity content, and it is difficult to remove impurities and purify later.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis process of doxofylline
  • Synthesis process of doxofylline
  • Synthesis process of doxofylline

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] This embodiment provides a synthesis process of doxofylline, adding theophylline, halogenated acetaldehyde ethylene acetal, acid-binding agent, catalyst in the organic solvent, theophylline and halogenated acetaldehyde ethylene acetal Under the action of an acid-binding agent and a catalyst, a substitution reaction occurs in an organic solvent to generate a crude product of doxofylline. As an alternative, the acid-binding agent is an organic strong base. Preferably in this embodiment, the organic solvent is N,N-dimethylformamide (DMF), the acid-binding agent is sodium / potassium alkoxide, and the catalyst is sodium iodide. Further preferably, the acid-binding agent is sodium methoxide. As an alternative, the halogen atoms in the haloacetaldehyde ethylene acetal may be fluorine, chlorine, bromine, or iodine, and the haloacetaldehyde ethylene acetal is added at least twice. Preferably in this embodiment, in order to reduce product toxicity and reduce environmental pollut...

Embodiment 2

[0055] The present embodiment provides a kind of synthetic technique of doxofylline, comprising the following steps:

[0056] (1) Preparation of doxofylline crude product mixed solution

[0057] Synthetic route such as figure 2 As shown, add N,N-dimethylformamide into the reaction tank under vacuum, add sodium iodide and sodium methoxide under stirring, raise the temperature to 50°C, then slowly add theophylline, stir evenly, then raise the temperature to 120°C for 2.5 hours. Preferably in this embodiment, the ratio of theophylline to N,N-dimethylformamide, sodium methoxide and sodium iodide is 1:3.42:0.45:0.0067.

[0058] Then add chloroacetaldehyde ethylene acetal twice, preferably in this embodiment, the addition ratio of theophylline and chloroacetaldehyde ethylene acetal is 1:1.02. First add 1 / 2 chloroacetaldehyde ethylene acetal into the reaction tank, heat to 130°C for 5 hours, then add the remaining 1 / 2 chloroacetaldehyde ethylene glycol and continue to keep warm at...

Embodiment 3

[0065] The present embodiment provides a kind of synthetic technique of doxofylline, comprising the following steps:

[0066] (1) Preparation of doxofylline crude product mixed solution

[0067] Synthetic route such as figure 2 As shown, add N,N-dimethylformamide into the reaction tank under vacuum, add sodium iodide and sodium methoxide under stirring, raise the temperature to 55°C, then slowly add theophylline, stir evenly and then raise the temperature to 125°C for 2 hours. Preferably in this embodiment, the ratio of theophylline to N,N-dimethylformamide, sodium methoxide and sodium iodide is 1:4:0.6:0.007.

[0068] Then add chloroacetaldehyde ethylene acetal twice, preferably in this embodiment, the addition ratio of theophylline and chloroacetaldehyde ethylene acetal is 1:1.05. First add 1 / 2 chloroacetaldehyde ethylene acetal into the reaction tank, heat to 135°C for 6 hours, then add the remaining 1 / 2 chloroacetaldehyde ethylene glycol and continue to keep warm at 135...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthesis process of doxofylline. The synthesis process comprises the following steps: adding theophylline, halogenated acetaldehyde ethylene glycol, an acid-binding agent and a catalyst into an organic solvent; under the action of an acid-binding agent and a catalyst, theophylline and halogenated acetaldehyde ethylene glycol are subjected to a substitution reaction in an organic solvent to generate a doxofylline crude product, and the doxofylline crude product is refined to obtain doxofylline; wherein the weight ratio of the theophylline to the organic solvent to the acid-binding agent to the catalyst is 1: (3-4): (0.3-0.6): (0.006-0.007), and the weight ratio of the theophylline to the halogenated acetaldehyde ethylene glycol is 1: (1-1.05).

Description

technical field [0001] The invention belongs to the field of drug synthesis, and in particular relates to a synthesis process of doxofylline. Background technique [0002] Doxofylline (Doxofylline) is a new phenyline drug, a derivative of xanthine, and its chemical name is 2-(7-theophylline methyl)-1,3-dioxolane. Doxofylline is a new generation of methylpurine derivatives that replace theophylline drugs. It is clinically used for the treatment of bronchial asthma, chronic obstructive pulmonary disease and other diseases such as dyspnea caused by bronchospasm. In comparison, the toxicity is low and non-addictive. [0003] At present, there are many synthetic routes of doxofylline. The main synthetic method is to prepare the intermediate theophylline first, and then combine the intermediate with ethylene glycol in N,N-dimethylformamide solvent to generate the crude product of doxofylline. However, this synthesis method introduces more solvents, resulting in high impurity con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D473/08
CPCC07D473/08
Inventor 张海立郭振军高艳波
Owner 赤峰万泽药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products